(Q35592471)

9 August 2017

title

Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study (English)

1 reference

9 August 2017

1

Renata Pasqualini

1 reference

9 August 2017

20

Wadih Arap

1 reference

9 August 2017

Randall E Millikan

2

1 reference

9 August 2017

Dawn R Christianson

3

1 reference

9 August 2017

Marina Cardó-Vila

4

1 reference

9 August 2017

Wouter H P Driessen

5

1 reference

9 August 2017

Ricardo J Giordano

6

1 reference

9 August 2017

Amin Hajitou

7

1 reference

9 August 2017

Anh G Hoang

8

1 reference

9 August 2017

Sijin Wen

9

1 reference

9 August 2017

Kirstin F Barnhart

10

1 reference

9 August 2017

Wallace B Baze

11

1 reference

9 August 2017

Valerie D Marcott

12

1 reference

9 August 2017

David H Hawke

13

1 reference

9 August 2017

Kim-Anh Do

14

1 reference

9 August 2017

Nora M Navone

15

1 reference

9 August 2017

Eleni Efstathiou

16

1 reference

9 August 2017

Patricia Troncoso

17

1 reference

9 August 2017

Roy R Lobb

18

1 reference

9 August 2017

Christopher J Logothetis

19

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 April 2015

1 reference

9 August 2017

1 reference

9 August 2017

volume

121

1 reference

9 August 2017

issue

14

1 reference

9 August 2017

page(s)

2411-2421

1 reference

The binding characteristics of a cyclic nonapeptide, c(CGRRAGGSC), in LNCaP human prostate cancer cells

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Increased survival with enzalutamide in prostate cancer after chemotherapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Cancer immunotherapy: a paradigm shift for prostate cancer treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Abiraterone and increased survival in metastatic prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Leveraging molecular heterogeneity of the vascular endothelium for targeted drug delivery and imaging

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Significant and sustained antitumor activity in post-docetaxel, castration-resistant prostate cancer with the CYP17 inhibitor abiraterone acetate

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Phase I study of samarium-153 lexidronam with docetaxel in castration-resistant metastatic prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

A ligand peptide motif selected from a cancer patient is a receptor-interacting site within human interleukin-11.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Beyond receptor expression levels: the relevance of target accessibility in ligand-directed pharmacodelivery systems

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Display technologies: application for the discovery of drug and gene delivery agents

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Ethics guidelines for research with the recently dead

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Reversal of obesity by targeted ablation of adipose tissue

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Targeting the prostate for destruction through a vascular address

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Steps toward mapping the human vasculature by phage display.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Anti-cancer activity of targeted pro-apoptotic peptides

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Revisiting ethical guidelines for research with terminal wean and brain-dead participants.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4490036

Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands

26 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.29344

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.29344

1 reference

9 August 2017

1 reference

9 August 2017

1 reference